Bristol-Myers' Opdualag fails Phase 3 melanoma study
Bristol-Myers Squibb (NYSE:BMY) said that the Phase 3 RELATIVITY-098 study of its drug Opdualag in the treatment of late-stage melanoma didn't meet its primary endpoint. The drugmaker had been testing ...
Onlymyhealth5d
From Your Lips To The Soles Of Your Feet, Unusual Places Where You Can Develop Skin Cancer
Skin cancer is a common type of cancer that can occur anywhere on the body Read to find out about the least expected areas ...